Longlong Si
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Molecular Biology top 10%
- Natural product bioactivities and synthesis
- RNA and protein synthesis mechanisms
Papers in
- Epidemiology 16
- Influenza Virus Research Studies 16
-
- Natural product bioactivities and synthesis 15
- RNA and protein synthesis mechanisms 2
- Co-authors
- Demin Zhou (29 shared papers)Lihe Zhang (20 shared papers)Sulong Xiao (19 shared papers)Yufei Wang (3 shared papers)Wenhan Lin (5 shared papers)Donald E. Ingber (4 shared papers)Zhenyu Tian (1 shared paper)Yongmin Zhang (10 shared papers)
- Journals
- European Journal of Medicinal Chemistry (7 papers)Nature Communications (4 papers)Nature Biomedical Engineering (3 papers)Advanced Science (3 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Longlong Si
65 papers receiving 2.5k citations
Longlong Si's Hit Papers
Peers
Comparison fields: 5 of 110
- Pharmacology 216
- Molecular Biology 827
- Biomedical Engineering 476
- Biotechnology 69
- Epidemiology 311
Countries citing papers authored by Longlong Si
This map shows the geographic impact of Longlong Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longlong Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longlong Si more than expected).
Fields of papers citing papers by Longlong Si
This network shows the impact of papers produced by Longlong Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longlong Si. The network helps show where Longlong Si may publish in the future.
Co-authors
The 25 scholars most cited alongside Longlong Si, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics Hit paper breakdown → | 2021 | 341 |
| 2 | 2018 | 183 | |
| 3 | 2016 | 143 | |
| 4 | 2014 | 136 | |
| 5 | Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip Hit paper breakdown → | 2022 | 136 |
| 6 | 2020 | 104 | |
| 7 | 2015 | 103 | |
| 8 | 2015 | 100 | |
| 9 | 2014 | 98 | |
| 10 | 2018 | 81 | |
| 11 | 2024 | 75 | |
| 12 | 2021 | 73 | |
| 13 | 2022 | 67 | |
| 14 | 2015 | 64 | |
| 15 | 2014 | 52 | |
| 16 | 2016 | 50 | |
| 17 | 2015 | 44 | |
| 18 | 2015 | 44 | |
| 19 | 2021 | 44 | |
| 20 | 2017 | 41 |
About Longlong Si
Longlong Si is a scholar working on Epidemiology, Molecular Biology, Pharmacology, Infectious Diseases and Biomedical Engineering, having authored 68 papers that have together received 2.6k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (16 papers), Natural product bioactivities and synthesis (15 papers), 3D Printing in Biomedical Research (7 papers), Microbial Natural Products and Biosynthesis (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), RNA and protein synthesis mechanisms (2 papers), Cellular Mechanics and Interactions (2 papers) and Electrospun Nanofibers in Biomedical Applications (2 papers). The work is most often cited by research in Pharmacology (216 citations), Molecular Biology (827 citations), Biomedical Engineering (476 citations), Biotechnology (69 citations) and Epidemiology (311 citations). Longlong Si has collaborated with scholars based in China, United States and France. Frequent co-authors include Demin Zhou, Lihe Zhang, Sulong Xiao, Yufei Wang, Wenhan Lin, Donald E. Ingber, Zhenyu Tian, Yongmin Zhang, Ge Fu and Yiming Wu. Their work appears in journals such as European Journal of Medicinal Chemistry, Nature Communications, Nature Biomedical Engineering, Advanced Science and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.